PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28365473 ↗2017Mixed findings

Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery.

MouseSpinal cord injuryContusionC57BL/6malen = 64 mice total; sham n=7; acute mitochondrial cohort n=27 in…Intraperitoneal10 mg/kg, dissolved in DMSO at 3 mg/mlFirst injection at 15 min or at 3 h after injury

Model: Severe mid-thoracic contusion spinal cord injury, T9 laminectomy and Infinite Horizons impactor at 75 kdyn (achieved force approximately 78 kdyn); sham was laminectomy only

Pioglitazone preserved acute mitochondrial respiration near sham levels and, with 5 days of daily dosing, improved locomotor recovery and increased grey and white matter sparing, but did not reduce chronic microglial and macrophage IBA-1 immunoreactivity.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.